BioSpace News Archive

July 2020 Services ISM® Report On Business®; Business Activity Index at 67.2%; New Orders Index at 67.7%; Employment Index at 42.1%; Supplier Deliveries Index at 55.2%

The Food and Drug Administration (FDA) has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables a critically ill patient to receive CT head imaging in the intensive care unit (ICU) while remaining in bed. Performing a CT head examination at

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, reported business highlights and financial results for its fiscal second quarter and six months ended June 30, 2020, and provided an overview of recent progress and accomplishments.

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and diseases associated with the microbiome, reported financial results and recent highlights for the second quarter ended June 30, 2020.

Knoxville Based Biotechnology Firm Enlists Expertise to Guide Company’s Scientific, Technology and Research Operations Amid Significant Business Growth In Recent Months

DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown , President and CEO, Michael H. Arenberg , Chief Financial Officer and Dr. WeiQi Lin , Executive Vice President of R&D will be participating in a fireside chat at the BTIG Biotechnology Conference 2020, Monday, August 10, 2020 at 11:00 a.m. EDT / 8:0

ThermoGenesis Holdings, Inc. announced that the Company will release its financial results for the second quarter ended June 30, 2020 and provide a corporate strategic update on Wednesday, August 12, 2020 after the close of trading.

Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing an

Genesis Drug Discovery & Development (GD3), a member of Genesis Biotechnology Group (GBG) announced today that it has acquired Comparative Biosciences, Inc. (CBI), a Contract Research Organization (CRO) located in Sunnyvale, California . CBI is specialized in GLP (Good Laboratory Practice) Toxicology and Safety Pharmacology proj

Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall said that as the large disinfectant manufacturers are reporting supply chain problems, RBII has no similar issues and is meeting customers needs. Other larger companies have reported their supply chains are stressed said Hall.